Pediatric low-grade gliomas: how modern biology reshapes the clinical field.

[1]  G. Peng,et al.  Non-coding RNAs: an emerging player in DNA damage response. , 2015, Mutation research. Reviews in mutation research.

[2]  R. McLendon,et al.  Efficacy of bevacizumab plus irinotecan in children with recurrent low-grade gliomas--a Pediatric Brain Tumor Consortium study. , 2014, Neuro-oncology.

[3]  S. Gabriel,et al.  Discovery and saturation analysis of cancer genes across 21 tumor types , 2014, Nature.

[4]  J. Barnholtz-Sloan,et al.  CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. , 2012, Neuro-oncology.

[5]  Roland Eils,et al.  Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma , 2013, Nature Genetics.

[6]  Thomas Bachelot,et al.  Targeting FGFR with Dovitinib (TKI258): Preclinical and Clinical Data in Breast Cancer , 2013, Clinical Cancer Research.

[7]  G. Counelis,et al.  Adult with cerebellar anaplastic pilocytic astrocytoma associated with BRAF V600E mutation and p16 loss. , 2013, Clinical neuropathology.

[8]  Liliana Goumnerova,et al.  Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factor MYBL1 , 2013, Proceedings of the National Academy of Sciences.

[9]  D. Gutmann,et al.  BRAFV600E mutation is a negative prognosticator in pediatric ganglioglioma , 2013, Acta Neuropathologica.

[10]  Heather L. Mulder,et al.  Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas , 2013, Nature Genetics.

[11]  A. Resnick,et al.  Paradoxical activation and RAF inhibitor resistance of BRAF protein kinase fusions characterizing pediatric astrocytomas , 2013, Proceedings of the National Academy of Sciences.

[12]  X. Wei,et al.  Sustained Response to Weekly Vinblastine in 2 Children With Pilomyxoid Astrocytoma Associated With Diencephalic Syndrome , 2013, Journal of pediatric hematology/oncology.

[13]  A. Buccoliero,et al.  Angiocentric glioma: clinical, morphological, immunohistochemical and molecular features in three pediatric cases. , 2013, Clinical neuropathology.

[14]  R. Siebert,et al.  High‐resolution genomic analysis suggests the absence of recurrent genomic alterations other than SMARCB1 aberrations in atypical teratoid/rhabdoid tumors , 2013, Genes, chromosomes & cancer.

[15]  E. Thiele,et al.  Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial , 2013, The Lancet.

[16]  T. MacDonald,et al.  A feasibility and efficacy study of rapamycin and erlotinib for recurrent pediatric low‐grade glioma (LGG) , 2013, Pediatric blood & cancer.

[17]  L. Garraway,et al.  Absence of oncogenic canonical pathway mutations in aggressive pediatric rhabdoid tumors , 2012, Pediatric blood & cancer.

[18]  D. Gutmann,et al.  Pediatric glioma-associated KIAA1549:BRAF expression regulates neuroglial cell growth in a cell type-specific and mTOR-dependent manner. , 2012, Genes & development.

[19]  M. Chintagumpala,et al.  Outcome of patients with pilocytic astrocytoma and leptomeningeal dissemination. , 2012, International journal of radiation oncology, biology, physics.

[20]  W. Snider,et al.  MEK Is a Key Regulator of Gliogenesis in the Developing Brain , 2012, Neuron.

[21]  D. Birnbaum,et al.  Search for distinctive markers in DNT and cortical grade II glioma in children: same clinicopathological and molecular entities? , 2012, Current topics in medicinal chemistry.

[22]  Matthew J. Betts,et al.  Dissecting the genomic complexity underlying medulloblastoma , 2012, Nature.

[23]  Gilbert Vezina,et al.  Randomized study of two chemotherapy regimens for treatment of low-grade glioma in young children: a report from the Children's Oncology Group. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  N. André,et al.  Bevacizumab and irinotecan in children with recurrent or refractory brain tumors: Toxicity and efficacy trends , 2012, Pediatric blood & cancer.

[25]  B. Yeap,et al.  Prospective study of health-related quality of life for children with brain tumors treated with proton radiotherapy. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  I. Pollack,et al.  Interplay among BRAF, p16, p53, and MIB1 in pediatric low-grade gliomas. , 2012, Neuro-oncology.

[27]  C. Hawkins,et al.  Phase II study of weekly vinblastine in recurrent or refractory pediatric low-grade glioma. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  David T. W. Jones,et al.  Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma , 2012, Nature.

[29]  Fausto J. Rodriguez,et al.  BRAF Alterations in Primary Glial and Glioneuronal Neoplasms of the Central Nervous System With Identification of 2 Novel KIAA1549: BRAF Fusion Variants , 2012, Journal of neuropathology and experimental neurology.

[30]  J. Stockman,et al.  Everolimus for Subependymal Giant-Cell Astrocytomas in Tuberous Sclerosis , 2012 .

[31]  C. Kruchko,et al.  CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. , 2012, Neuro-oncology.

[32]  M. Masruha,et al.  Pediatric Central Nervous System Tumors: A Single-center Experience From 1989 to 2009 , 2011, Journal of pediatric hematology/oncology.

[33]  C. Sarkar,et al.  Molecular profile of oligodendrogliomas in young patients. , 2011, Neuro-oncology.

[34]  M. Gelabert-González,et al.  Intracranial gangliogliomas. A review of a series of 20 patients , 2011 .

[35]  A. G. Allut,et al.  [Intracranial gangliogliomas. A review of a series of 20 patients]. , 2011, Neurologia.

[36]  I. Pollack,et al.  A phase 1 study of vinblastine in combination with carboplatin for children with low-grade gliomas: a Children's Oncology Group phase 1 consortium study. , 2011, Neuro-oncology.

[37]  C. Hawkins,et al.  Feasibility and efficacy of repeated chemotherapy for progressive pediatric low‐grade gliomas , 2011, Pediatric blood & cancer.

[38]  L. Margraf,et al.  Proliferative and metabolic markers in incompletely excised pediatric pilocytic astrocytomas--an assessment of 3 new variables in predicting clinical outcome. , 2011, Neuro-oncology.

[39]  T. Pietsch,et al.  Impact of chemotherapy on disseminated low‐grade glioma in children and adolescents: Report from the HIT‐LGG 1996 trial , 2011, Pediatric blood & cancer.

[40]  Matthew M. Pearson,et al.  Pediatric cerebellar pilomyxoid-spectrum astrocytomas. , 2011, Journal of neurosurgery. Pediatrics.

[41]  I. Fried,et al.  Pediatric temporal low-grade glial tumors: epilepsy outcome following resection in 48 children , 2011, Child's Nervous System.

[42]  J. Reddy,et al.  Oncogene-Induced Senescence and its Role in Tumor Suppression , 2011, Journal of Mammary Gland Biology and Neoplasia.

[43]  S. Pileri,et al.  BRAF mutations in hairy-cell leukemia. , 2011, The New England journal of medicine.

[44]  J. Wisoff,et al.  Primary Neurosurgery for Pediatric Low-Grade Gliomas: A Prospective Multi-Institutional Study From the Children's Oncology Group , 2011, Neurosurgery.

[45]  N. Alon,et al.  BRAF-KIAA1549 Fusion Predicts Better Clinical Outcome in Pediatric Low-Grade Astrocytoma , 2011, Clinical Cancer Research.

[46]  S. Pfister,et al.  Genetic Aberrations Leading to MAPK Pathway Activation Mediate Oncogene-Induced Senescence in Sporadic Pilocytic Astrocytomas , 2011, Clinical Cancer Research.

[47]  G. Nikkhah,et al.  BRAF Activation Induces Transformation and Then Senescence in Human Neural Stem Cells: A Pilocytic Astrocytoma Model , 2011, Clinical Cancer Research.

[48]  Jing Ma,et al.  RAF gene fusion breakpoints in pediatric brain tumors are characterized by significant enrichment of sequence microhomology. , 2011, Genome research.

[49]  Robert N. Anderson,et al.  Annual Report to the Nation on the Status of Cancer, 1975–2007, Featuring Tumors of the Brain and Other Nervous System , 2011, Journal of the National Cancer Institute.

[50]  A. Iafrate,et al.  BRAF V600E Mutations Are Common in Pleomorphic Xanthoastrocytoma: Diagnostic and Therapeutic Implications , 2011, PloS one.

[51]  David T. W. Jones,et al.  Oncogenic FAM131B–BRAF fusion resulting from 7q34 deletion comprises an alternative mechanism of MAPK pathway activation in pilocytic astrocytoma , 2011, Acta Neuropathologica.

[52]  M. Esteller,et al.  Cancer epigenetics reaches mainstream oncology , 2011, Nature Medicine.

[53]  T. Merchant,et al.  Survival and long-term health and cognitive outcomes after low-grade glioma. , 2011, Neuro-oncology.

[54]  Kirsten Schmieder,et al.  Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma , 2011, Acta Neuropathologica.

[55]  T. MacDonald,et al.  Phase I trial of lenalidomide in pediatric patients with recurrent, refractory, or progressive primary CNS tumors: Pediatric Brain Tumor Consortium study PBTC-018. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[56]  T. Kawase,et al.  Single-Copy Gain of Chromosome 1q Is a Negative Prognostic Marker in Pediatric Nonependymal, Nonpilocytic Gliomas , 2011, Neurosurgery.

[57]  D. Johnston,et al.  The use and effectiveness of temozolomide in children with central nervous system tumours: a survey from the Canadian Paediatric Brain Tumour Consortium. , 2011, Current oncology.

[58]  K. Oguz,et al.  Benign cerebellar pilocytic astrocytomas in children. , 2011, Turkish neurosurgery.

[59]  S. Vandenberg,et al.  OLIG2 is differentially expressed in pediatric astrocytic and in ependymal neoplasms , 2010, Journal of Neuro-Oncology.

[60]  Jo-Fen Liu,et al.  A multivariate analysis of factors determining tumor progression in childhood low-grade glioma: a population-based cohort study (CCLG CNS9702). , 2010, Neuro-oncology.

[61]  A. Byars,et al.  Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis. , 2010, The New England journal of medicine.

[62]  S. Shurtleff,et al.  MYB upregulation and genetic aberrations in a subset of pediatric low-grade gliomas , 2010, Acta Neuropathologica.

[63]  S. Gabriel,et al.  Advances in understanding cancer genomes through second-generation sequencing , 2010, Nature Reviews Genetics.

[64]  D. Hargrave,et al.  Vincristine and carboplatin chemotherapy for unresectable and/or recurrent low‐grade astrocytoma of the brainstem , 2010, Pediatric blood & cancer.

[65]  P. Adamson,et al.  A phase II trial and pharmacokinetic study of oxaliplatin in children with refractory solid tumors: A Children's Oncology Group study , 2010, Pediatric blood & cancer.

[66]  Y. Cheng,et al.  Distribution of Lysosome-Associated Membrane Proteins-1 and -2, and Cathepsin D in Eosinophilic Granular Bodies: Possible Relationship to Cyst Development in Pilocytic Astrocytomas , 2010, The Journal of international medical research.

[67]  R. Prayson.  Tumours arising in the setting of paediatric chronic epilepsy , 2010, Pathology.

[68]  J. Biegel,et al.  Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomas. , 2010, Neuro-oncology.

[69]  E. Hoving,et al.  Tumour vasculature and angiogenic profile of paediatric pilocytic astrocytoma; is it much different from glioblastoma? , 2010, Neuropathology and applied neurobiology.

[70]  D. Sandberg,et al.  Malignant transformation of an optic pathway glioma without prior radiation therapy. , 2010, Journal of neurosurgery. Pediatrics.

[71]  T. Pietsch,et al.  Natural history and management of low-grade glioma in NF-1 children , 2010, Journal of Neuro-Oncology.

[72]  Chao Zhang,et al.  RAF inhibitors transactivate RAF dimers and ERK signaling in cells with wild-type BRAF , 2010, Nature.

[73]  M. K. Cooper,et al.  Activation of the Hedgehog pathway in pilocytic astrocytomas , 2010, Neuro-oncology.

[74]  M. Berger,et al.  Phase II TPDCV protocol for pediatric low-grade hypothalamic/chiasmatic gliomas: 15-year update , 2010, Journal of Neuro-Oncology.

[75]  D. Na,et al.  Nonenhancing Intramedullary Astrocytomas and Other MR Imaging Features: A Retrospective Study and Systematic Review , 2010, American Journal of Neuroradiology.

[76]  D. Riva,et al.  A lower-dose, lower-toxicity cisplatin–etoposide regimen for childhood progressive low-grade glioma , 2010, Journal of Neuro-Oncology.

[77]  Hanlee P. Ji,et al.  Oncogenic BRAF mutation with CDKN2A inactivation is characteristic of a subset of pediatric malignant astrocytomas. , 2010, Cancer research.

[78]  D. Ellison,et al.  A multivariate analysis of factors determining tumor progression in childhood low-grade glioma : a population-based cohort study ( CCLG CNS 9702 ) , 2010 .

[79]  E. Hattingen,et al.  Spectroscopy of untreated pilocytic astrocytomas: do children and adults share some metabolic features in addition to their morphologic similarities? , 2010, Child's Nervous System.

[80]  R. McLendon,et al.  IDH1 and IDH2 mutations in gliomas. , 2009, The New England journal of medicine.

[81]  P. Striano,et al.  Epilepsy associated with supratentorial brain tumors under 3 years of life , 2009, Epilepsy Research.

[82]  Keith L. Ligon,et al.  Profiling Critical Cancer Gene Mutations in Clinical Tumor Samples , 2009, PloS one.

[83]  M. Watson,et al.  Alterations of BRAF and HIPK2 loci predominate in sporadic pilocytic astrocytoma , 2009, Neurology.

[84]  M. Fisher,et al.  Pediatric Low-Grade Gliomas , 2009, Journal of child neurology.

[85]  C. Hawkins,et al.  Survival and functional outcome of childhood spinal cord low-grade gliomas. Clinical article. , 2009, Journal of neurosurgery. Pediatrics.

[86]  T. Merchant,et al.  Phase II trial of conformal radiation therapy for pediatric low-grade glioma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[87]  T. Merchant,et al.  Late effects of conformal radiation therapy for pediatric patients with low-grade glioma: prospective evaluation of cognitive, endocrine, and hearing deficits. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[88]  A. Montpetit,et al.  Duplication of 7q34 is specific to juvenile pilocytic astrocytomas and a hallmark of cerebellar and optic pathway tumours , 2009, British Journal of Cancer.

[89]  T. Shaikh,et al.  Duplication of 7q34 in Pediatric Low‐Grade Astrocytomas Detected by High‐Density Single‐Nucleotide Polymorphism‐Based Genotype Arrays Results in a Novel BRAF Fusion Gene , 2009, Brain pathology.

[90]  T. MacDonald,et al.  Objective response of multiply recurrent low‐grade gliomas to bevacizumab and irinotecan , 2009, Pediatric blood & cancer.

[91]  A. Lage,et al.  Clinical experience with nimotuzumab in cuban pediatric patients with brain tumors, 2005 to 2007. , 2009, MEDICC review.

[92]  M. K. Cooper,et al.  Targeted inhibition of the Hedgehog pathway in established malignant glioma xenografts enhances survival , 2009, Oncogene.

[93]  C. Passamonti,et al.  Cingulate epilepsy in a child with a low-grade glioma , 2009, Child's Nervous System.

[94]  Jing Ma,et al.  Activation of the ERK/MAPK pathway: a signature genetic defect in posterior fossa pilocytic astrocytomas , 2009, The Journal of pathology.

[95]  D. Pearson,et al.  Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549:BRAF fusion in activating the MAPK pathway in pilocytic astrocytoma , 2009, Oncogene.

[96]  L. Margraf,et al.  Predictors of tumor progression among children with gangliogliomas. Clinical article. , 2009, Journal of neurosurgery. Pediatrics.

[97]  Y. Sawamura,et al.  Chemotherapy with cisplatin and vincristine for optic pathway/hypothalamic astrocytoma in young children. , 2009, Japanese journal of clinical oncology.

[98]  R. Timmerman,et al.  Gamma Knife Stereotactic Radiosurgery for Low-Grade Astrocytomas , 2009, Stereotactic and Functional Neurosurgery.

[99]  G. Alexiou,et al.  Benign Lesions Accompanied by Intractable Epilepsy in Children , 2009, Journal of child neurology.

[100]  Y. Takeshima,et al.  Clinicopathological and immunohistochemical features of three pilomyxoid astrocytomas: Comparative study with 11 pilocytic astrocytomas , 2009, Pathology international.

[101]  I. Qaddoumi,et al.  Pediatric low-grade gliomas and the need for new options for therapy: why and how? , 2009, Cancer biology & therapy.

[102]  N. Jersey..  Predictors of tumor progression among children with gangliogliomas , 2009 .

[103]  S. Orkin.  Oncology of infancy and childhood , 2009 .

[104]  S. Pfister,et al.  Pediatric gliomas. , 2009, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[105]  Frank M. Sacks,et al.  IDH 1 and IDH 2 Mutations in Gliomas , 2009 .

[106]  F. Saggioro,et al.  In pursuit of prognostic factors in children with pilocytic astrocytomas , 2009, Child's Nervous System.

[107]  H. Duffau,et al.  Clinical epidemiology for childhood primary central nervous system tumors , 2009, Journal of Neuro-Oncology.

[108]  J. Mocco,et al.  Magnetic resonance imaging characteristics of pilomyxoid astrocytoma , 2008, Neurological research.

[109]  David T. W. Jones,et al.  Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas. , 2008, Cancer research.

[110]  M. Berhouma,et al.  Calcified pilocytic astrocytoma of the medulla mimicking a brainstem "stone". , 2008, Pathologica.

[111]  Y. Paksoy,et al.  Malignant glioblastomatous transformation of a low-grade glioma in a child , 2008, Child's Nervous System.

[112]  Kai-Ping Chang,et al.  Responsiveness of progressive optic pathway tumors to cisplatin-based chemotherapy in children , 2008, Child's Nervous System.

[113]  M. Watson,et al.  High-resolution, dual-platform aCGH analysis reveals frequent HIPK2 amplification and increased expression in pilocytic astrocytomas , 2008, Oncogene.

[114]  Yuko Tanaka,et al.  Diversity of glial cell components in pilocytic astrocytoma , 2008, Neuropathology : official journal of the Japanese Society of Neuropathology.

[115]  M. Repka,et al.  Outcome analysis of childhood low‐grade astrocytomas , 2008, Pediatric blood & cancer.

[116]  A. Hoischen,et al.  Comprehensive Characterization of Genomic Aberrations in Gangliogliomas by CGH, Array‐based CGH and Interphase FISH , 2008, Brain pathology.

[117]  T. Siu,et al.  Radical resection of focal brainstem gliomas: is it worth doing? , 2008, Child's Nervous System.

[118]  S. Joseph,et al.  Spontaneous Regression of Low-Grade Gliomas in Pediatric Patients without Neurofibromatosis , 2008, Pediatric Neurosurgery.

[119]  G. Reifenberger,et al.  BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas. , 2008, The Journal of clinical investigation.

[120]  P. Novaes,et al.  Unusual dissemination patterns of low-grade astrocytomas in childhood. , 2008, Arquivos de neuro-psiquiatria.

[121]  B. O'neill,et al.  Gliomas in Neurofibromatosis Type 1: A Clinicopathologic Study of 100 Patients , 2008, Journal of neuropathology and experimental neurology.

[122]  F. Costa,et al.  Non-coding RNAs, epigenetics and complexity. , 2008, Gene.

[123]  D. Johnston,et al.  Carboplatin hypersensitivity reaction in pediatric patients with low‐grade glioma , 2008, Cancer.

[124]  田中 優子.  Diversity of glial cell components in pilocytic astrocytoma , 2008 .

[125]  J. Pimentel,et al.  Genetic alterations in a papillary glioneuronal tumor. , 2008, Journal of neurosurgery. Pediatrics.

[126]  S. Torp,et al.  The clinical value of Ki-67/MIB-1 labeling index in human astrocytomas , 2008, Pathology & Oncology Research.

[127]  J. A. Heath,et al.  Temozolomide in pediatric low‐grade glioma , 2007, Pediatric blood & cancer.

[128]  C. Parsa,et al.  Juvenile pilocytic astrocytomas do not undergo spontaneous malignant transformation: grounds for designation as hamartomas , 2007, British Journal of Ophthalmology.

[129]  H. Friedman,et al.  Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumors , 2007, Cancer.

[130]  C. Bruggers,et al.  A Phase 2 Feasibility Study of Sequential, Dose Intensive Chemotherapy to Treat Progressive Low-grade Gliomas in Children , 2007, Journal of pediatric hematology/oncology.

[131]  B. Nadel,et al.  The C-MYB locus is involved in chromosomal translocation and genomic duplications in human T-cell acute leukemia (T-ALL), the translocation defining a new T-ALL subtype in very young children. , 2007, Blood.

[132]  B. Scheithauer,et al.  The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.

[133]  Adrian Bird,et al.  Perceptions of epigenetics , 2007, Nature.

[134]  Rob Pieters,et al.  Duplication of the MYB oncogene in T cell acute lymphoblastic leukemia , 2007, Nature Genetics.

[135]  Mitsutoshi Nakamura,et al.  Molecular pathogenesis of pediatric astrocytic tumors. , 2007, Neuro-oncology.

[136]  A. Friedman,et al.  Temozolomide in children with progressive low-grade glioma. , 2007, Neuro-oncology.

[137]  C. Weiller,et al.  Further evidence for a somatic KRAS mutation in a pilocytic astrocytoma. , 2007, Neuropediatrics.

[138]  M. Mokry,et al.  Diencephalic Syndrome: A Frequently Delayed Diagnosis in Failure to Thrive , 2007, Klinische Padiatrie.

[139]  Hongye Liu,et al.  Olig2-Regulated Lineage-Restricted Pathway Controls Replication Competence in Neural Stem Cells and Malignant Glioma , 2007, Neuron.

[140]  K. Wong,et al.  Expression of oligodendroglial differentiation markers in pilocytic astrocytomas identifies two clinical subsets and shows a significant correlation with proliferation index and progression free survival , 2007, Journal of Neuro-Oncology.

[141]  D. Louis.  WHO classification of tumours of the central nervous system , 2007 .

[142]  Wan-Yuo Guo,et al.  Gamma Knife surgery for low-grade astrocytomas: evaluation of long-term outcome based on a 10-year experience. , 2006, Journal of neurosurgery.

[143]  B. Meléndez,et al.  BCR gene disruption in a pilomyxoid astrocytoma , 2006, Neuropathology : official journal of the Japanese Society of Neuropathology.

[144]  H. Caron,et al.  Prognostic factors for progression of childhood optic pathway glioma: a systematic review. , 2006, European journal of cancer.

[145]  S. Ahn,et al.  Effectiveness of novel combination chemotherapy, consisting of 5-fluorouracil, vincristine, cyclophosphamide and etoposide, in the treatment of low-grade gliomas in children , 2006, Journal of Neuro-Oncology.

[146]  C. Urban,et al.  Residual or Recurrent Cerebellar Low-Grade Glioma in Children after Tumor Resection: Is Re-Treatment Needed? A Single Center Experience from 1983 to 2003 , 2006, Pediatric Neurosurgery.

[147]  E. Podgoršak,et al.  Hypofractionated Stereotactic Radiotherapy for Low Grade Glioma at McGill University: Long-term Follow-up , 2006, Technology in cancer research & treatment.

[148]  K. Kawakami,et al.  BRAF mutations are associated with distinctive clinical, pathological and molecular features of colorectal cancer independently of microsatellite instability status , 2006, Molecular Cancer.

[149]  M. Watson,et al.  RAS pathway activation and an oncogenic RAS mutation in sporadic pilocytic astrocytoma , 2005, Neurology.

[150]  D. Seidenwurm,et al.  Angiocentric Neuroepithelial Tumor (ANET): A New Epilepsy‐Related Clinicopathological Entity with Distinctive MRI , 2005, Brain pathology.

[151]  N. Amariglio,et al.  Epidermal growth factor receptor gene amplification and expression in disseminated pediatric low-grade gliomas. , 2005, Journal of neurosurgery.

[152]  B. Harding,et al.  Spontaneous regression of residual low-grade cerebellar pilocytic astrocytomas in children , 2005, Pediatric Radiology.

[153]  S. Rosemberg,et al.  Epidemiology of pediatric tumors of the nervous system according to the WHO 2000 classification: a report of 1,195 cases from a single institution , 2005, Child's Nervous System.

[154]  A. Huang,et al.  Weekly vinblastine in pediatric low‐grade glioma patients with carboplatin allergic reaction , 2005, Cancer.

[155]  D. Honorato,et al.  Intrinsic tectal low grade astrocytomas: is surgical removal an alternative treatment? Long-term outcome of eight cases. , 2005, Arquivos de neuro-psiquiatria.

[156]  H. Kooy,et al.  Stereotactic radiotherapy for localized low-grade gliomas in children: final results of a prospective trial. , 2003, International journal of radiation oncology, biology, physics.

[157]  M. Berger,et al.  Favorable prognosis for brainstem gliomas in neurofibromatosis , 1989, Journal of Neuro-Oncology.

[158]  J. Krischer,et al.  A phase II study of every other day high-dose ifosfamide in pediatric brain tumors , 2005, Journal of Neuro-Oncology.

[159]  D. Louis,et al.  Losses of chromosomes 1p and 19q are rare in pediatric oligodendrogliomas , 2005, Acta Neuropathologica.

[160]  L. Neder,et al.  MIB-1 labeling index in astrocytic tumors--a clinicopathologic study. , 2004, Clinical neuropathology.

[161]  R. Kortmann,et al.  Low Grade Chiasmatic-Hypothalamic Glioma - Carboplatin and Vincristin Chemotherapy Effectively Defers Radiotherapy within a Comprehensive Treatment Strategy , 2004, Klinische Padiatrie.

[162]  D. Rating,et al.  Impact of location on outcome in children with low‐grade oligodendroglioma , 2004, Pediatric blood & cancer.

[163]  F. Heppner,et al.  Gene expression profiling and subgroup identification of oligodendrogliomas , 2004, Oncogene.

[164]  R. Fimmers,et al.  Supratentorial gangliogliomas: Histopathologic grading and tumor recurrence in 184 patients with a median follow‐up of 8 years , 2004, Cancer.

[165]  S. Plon,et al.  Outcomes of systematic screening for optic pathway tumors in children with Neurofibromatosis Type 1 , 2004, American journal of medical genetics. Part A.

[166]  Laurent Capelle,et al.  Preferential brain locations of low‐grade gliomas , 2004, Cancer.

[167]  P. Tam,et al.  Ubiquitous Aberrant RASSF1A Promoter Methylation in Childhood Neoplasia1 , 2004, Clinical Cancer Research.

[168]  D. Lancaster,et al.  Tolerance of Nitrosurea-Based Multiagent Chemotherapy Regime for Low-Grade Pediatric Gliomas , 2003, Journal of Neuro-Oncology.

[169]  R. Onimaru,et al.  Three-dimensional Conformal Radiotherapy for Astrocytic Tumors Involving the Eloquent Area in Children and Young Adults , 2002, Journal of Neuro-Oncology.

[170]  H. Budka,et al.  Proliferative Activity as Measured by MIB-1 Labeling Index and Long-term Outcome of Cerebellar Juvenile Pilocytic Astrocytomas , 2002, Journal of Neuro-Oncology.

[171]  A. Lasorella,et al.  Hypersensitivity Reactions to Carboplatin in Children , 2002, Journal of Neuro-Oncology.

[172]  F. Kayaselçuk,et al.  PCNA and Ki-67 in Central Nervous System Tumors: Correlation with the Histological Type and Grade , 2002, Journal of Neuro-Oncology.

[173]  H. Budka,et al.  Proliferative Activity as Measured by MIB-1 Labeling Index and Long-term Outcome of Visual Pathway Astrocytomas in Children , 1999, Journal of Neuro-Oncology.

[174]  V. Aquino,et al.  Carboplatin for the Treatment of Children with Newly Diagnosed Optic Chiasm Gliomas: A Phase II Study , 1999, Journal of Neuro-Oncology.

[175]  J. Koudstaal,et al.  The proliferative potential of the pilocytic astrocytoma: The relation between MIB-1 labeling and clinical and neuro-radiological follow-up , 1998, Journal of Neuro-Oncology.

[176]  M. Prados,et al.  Treatment of pediatric low-grade gliomas with a nitrosourea-based multiagent chemotherapy regimen , 1997, Journal of Neuro-Oncology.

[177]  J. Finlay,et al.  Chemotherapy with vincristine (VCR) and etoposide (VP-16) in children with low-grade astrocytoma , 1992, Journal of Neuro-Oncology.

[178]  P. Tam,et al.  Ubiquitous Aberrant RASSF 1 A Promoter Methylation in Childhood Neoplasia 1 , 2004 .

[179]  S. Vandenberg,et al.  Tuber and subependymal giant cell astrocytoma associated with tuberous sclerosis: an immunohistochemical, ultrastructural, and immunoelectron microscopic study , 2004, Acta Neuropathologica.

[180]  Ajay N. Jain,et al.  Determinants of BRAF mutations in primary melanomas. , 2003, Journal of the National Cancer Institute.

[181]  D. Frappaz,et al.  Progression-free survival in children with optic pathway tumors: dependence on age and the quality of the response to chemotherapy--results of the first French prospective study for the French Society of Pediatric Oncology. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[182]  Daniel H. Geschwind,et al.  Cancerous stem cells can arise from pediatric brain tumors , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[183]  P. Burger,et al.  Phase 2 study of idarubicin in pediatric brain tumors: Pediatric Oncology Group study POG 9237. , 2003, Neuro-oncology.

[184]  F. Gilles,et al.  Outcome of children with centrally reviewed low‐grade gliomas treated with chemotherapy with or without radiotherapy on Children's Cancer Group high‐grade glioma study CCG‐945 , 2003, Cancer.

[185]  D. Figarella-Branger,et al.  Pilocytic Astrocytomas in Children: Prognostic Factors—A Retrospective Study of 80 Cases , 2003, Neurosurgery.

[186]  J. Reisch,et al.  Study of the MIB-1 labeling index as a predictor of tumor progression in pilocytic astrocytomas in children and adolescents. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[187]  K. Fukunaga,et al.  Neurofibromatosis Type I Tumor Suppressor Neurofibromin Regulates Neuronal Differentiation via Its GTPase-activating Protein Function toward Ras* , 2003, Journal of Biological Chemistry.

[188]  Y. Suh,et al.  Dysembryoplastic Neuroepithelial Tumor , 2003, Acta Cytologica.

[189]  R. Schwartz,et al.  Optic Pathway Gliomas in Children With and Without Neurofibromatosis 1 , 2003, Journal of child neurology.

[190]  Jeffrey C. Allen,et al.  Leptomeningeal dissemination at diagnosis of pediatric low-grade neuroepithelial tumors. , 2003, Neuro-oncology.

[191]  G. Perilongo,et al.  Low-grade gliomas and leptomeningeal dissemination: a poorly understood phenomenon , 2003, Child's Nervous System.

[192]  Jacques Grill,et al.  Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1): a retrospective study of 104 patients. , 2003, Brain : a journal of neurology.

[193]  W. Reik,et al.  Frequent RASSF1A tumour suppressor gene promoter methylation in Wilms' tumour and colorectal cancer , 2002, Oncogene.

[194]  D. Riva,et al.  High response rate to cisplatin/etoposide regimen in childhood low-grade glioma. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[195]  James M. Olson,et al.  Medulloblastoma Growth Inhibition by Hedgehog Pathway Blockade , 2002, Science.

[196]  L. Margraf,et al.  Prognostic Factors in Children and Adolescents with Low-Grade Oligodendrogliomas , 2002, Pediatric Neurosurgery.

[197]  H. Friedman,et al.  Phase II study of carboplatin in children with progressive low-grade gliomas. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[198]  P. Lai,et al.  Diffusion-weighted MRI features of brain abscess and cystic or necrotic brain tumors: comparison with conventional MRI. , 2002, Clinical imaging.

[199]  G. Reifenberger,et al.  [The new WHO classification of tumors of the nervous system 2000. Pathology and genetics]. , 2002, Der Pathologe.

[200]  I. Casteels,et al.  Visual pathway glioma in children treated with chemotherapy. , 2002, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[201]  V. Khoo,et al.  Stereotactically guided conformal radiotherapy for progressive low-grade gliomas of childhood. , 2002, International journal of radiation oncology, biology, physics.

[202]  K. Choy,et al.  Impaired expression and promotor hypermethylation of O6-methylguanine-DNA methyltransferase in retinoblastoma tissues. , 2002, Investigative ophthalmology & visual science.

[203]  S. Kuerbitz,et al.  Hypermethylation of the imprinted NNAT locus occurs frequently in pediatric acute leukemia. , 2002, Carcinogenesis.

[204]  L. Mcgavran,et al.  Cytogenetics in pediatric low-grade astrocytomas. , 2002, Medical and pediatric oncology.

[205]  J. Slater,et al.  Conformal Proton Radiation Therapy for Pediatric Low-Grade Astrocytomas , 2002, Strahlentherapie und Onkologie.

[206]  J. Michaelis,et al.  Population‐based epidemiologic data on brain tumors in German children , 2001, Cancer.

[207]  S. Blaser,et al.  Optic pathway glioma: correlation of imaging findings with the presence of neurofibromatosis. , 2001, AJNR. American journal of neuroradiology.

[208]  I. Pollack,et al.  Age and TP53 mutation frequency in childhood malignant gliomas: results in a multi-institutional cohort. , 2001, Cancer research.

[209]  W. Paulus,et al.  Epidemiology of central nervous system tumors in childhood and adolescence based on the new WHO classification , 2001, Child’s Nervous System.

[210]  P. Fisher,et al.  Weekly Dosing of Carboplatin Increases Risk of Allergy in Children , 2001, Journal of pediatric hematology/oncology.

[211]  Y. Mori,et al.  Gamma knife radiosurgery for low-grade astrocytomas: results of long-term follow up. , 2000, Journal of neurosurgery.

[212]  B. Korf.  Malignancy in neurofibromatosis type 1. , 2000, The oncologist.

[213]  J M Trent,et al.  MYB oncogene amplification in hereditary BRCA1 breast cancer. , 2000, Cancer research.

[214]  J. Langston,et al.  Tamoxifen and carboplatin for children with low-grade gliomas: a pilot study at St. Jude Children's Research Hospital. , 2000, Journal of pediatric hematology/oncology.

[215]  R. McLendon,et al.  Gliomas of the optic nerve: histological, immunohistochemical (MIB-1 and p53), and MRI analysis , 2000, Acta Neuropathologica.

[216]  R. Packer,et al.  Spontaneous Regression of Low-Grade Astrocytomas in Childhood , 2000, Pediatric Neurosurgery.

[217]  B. Scheithauer,et al.  Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[218]  Bleyer Wa.  Epidemiologic impact of children with brain tumors. , 1999 .

[219]  J. Strain,et al.  Successful Use of Intracavitary Bleomycin for Low-Grade Astrocytoma Tumor Cyst , 1999, Pediatric Neurosurgery.

[220]  J. Herman,et al.  Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5' CpG island methylation. , 1999, Cancer research.

[221]  M. Clementi,et al.  Spontaneous Partial Regression of Low-Grade Glioma in Children With Neurofibromatosis-1: A Real Possibility , 1999, Journal of child neurology.

[222]  J. Langston,et al.  Cyclophosphamide for the treatment of progressive low-grade astrocytoma: a Pediatric Oncology Group phase II Study. , 1999, Journal of pediatric hematology/oncology.

[223]  C. Sainte-Rose,et al.  Radiation‐induced cerebral vasculopathy in children with neurofibromatosis and optic pathway glioma , 1999, Annals of neurology.

[224]  A. Bleyer,et al.  Epidemiologic impact of children with brain tumors , 1999, Child's Nervous System.

[225]  R. Prayson,et al.  Cyclin D1 and MIB-1 immunohistochemistry in pilocytic astrocytomas: a study of 48 cases. , 1998, Human Pathology.

[226]  B. Scheithauer,et al.  Malignant tumors of the kidney, brain, and soft tissues in children and young adults with the tuberous sclerosis complex , 1998, Cancer.

[227]  M. Berger,et al.  Predicting disease progression in childhood cerebellar astrocytoma , 1998, Child's Nervous System.

[228]  J. Piatt,et al.  Spontaneous Involution of a Diencephalic Astrocytoma , 1998, Pediatric Neurosurgery.

[229]  M. Choux,et al.  Are juvenile pilocytic astrocytomas benign tumors? A cytogenetic study in 24 cases. , 1998, Cancer genetics and cytogenetics.

[230]  J. Montes,et al.  Low-grade astrocytomas in children: evolving management strategies. , 1998, International journal of radiation oncology, biology, physics.

[231]  J. Haase,et al.  Epidemiology and prognosis in children treated for intracranial tumours in Denmark 1960–1984 , 1998, Child’s Nervous System.

[232]  R. McLendon,et al.  Chromosomal characteristics of childhood brain tumors. , 1997, Cancer genetics and cytogenetics.

[233]  S Povey,et al.  Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. , 1997, Science.

[234]  H. Vogel,et al.  Cytogenetic analysis of 120 primary pediatric brain tumors and literature review. , 1997, Cancer genetics and cytogenetics.

[235]  J. Langston,et al.  Low-grade astrocytoma: a decade of experience at St. Jude Children's Research Hospital. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[236]  H. Friess,et al.  Characterization of a high copy number amplification at 6q24 in pancreatic cancer identifies c-myb as a candidate oncogene. , 1997, Cancer research.

[237]  G. Basso,et al.  Diencephalic syndrome and disseminated juvenile pilocytic astrocytomas of the hypothalamic‐optic chiasm region , 1997, Cancer.

[238]  J. Finlay,et al.  Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas. , 1997, Journal of neurosurgery.

[239]  D. Louis,et al.  Optic pathway gliomas in children with neurofibromatosis 1: Consensus statement from the nf1 optic pathway glioma task force , 1997 .

[240]  R. McLendon,et al.  Successful treatment of childhood pilocytic astrocytomas metastatic to the leptomeninges with high-dose cyclophosphamide. , 1996, Medical and pediatric oncology.

[241]  I. Pollack,et al.  The management of brainstem gliomas in patients with neurofibromatosis 1 , 1996, Neurology.

[242]  J. Brockmöller,et al.  p53 gene mutations in human astrocytic brain tumors including pilocytic astrocytomas. , 1996, Human pathology.

[243]  H. Morris,et al.  Dysembryoplastic neuroepithelial tumor: a clinicopathologic and immunohistochemical study of 11 tumors including MIB1 immunoreactivity. , 1996, Clinical neuropathology.

[244]  S. Sallan,et al.  Phase II evaluation of topotecan for pediatric central nervous system tumors. , 1996, Cancer.

[245]  D. Louis,et al.  Molecular genetic alterations in pleomorphic xanthoastrocytoma , 1996, Acta Neuropathologica.

[246]  L. Rorke,et al.  Long-term outcome of hypothalamic/chiasmatic astrocytomas in children treated with conservative surgery. , 1995, Journal of neurosurgery.

[247]  J. Sawyer,et al.  Low-grade astrocytoma with a complex four-breakpoint inversion of chromosome 8 as the sole cytogenetic aberration. , 1995, Cancer genetics and cytogenetics.

[248]  D. Schofield,et al.  Nonrandom chromosomal gains in pilocytic astrocytomas of childhood. , 1995, Human pathology.

[249]  M. Castello,et al.  Does chemotherapy have a role in low-grade astrocytoma management? A report of 13 cases. , 1995, Medical and pediatric oncology.

[250]  R. Prayson,et al.  Cortical Architectural Abnormalities and MIB1 Immunoreactivity in Gangliogliomas: A Study of 60 Patients with Intracranial Tumors , 1995, Journal of neuropathology and experimental neurology.

[251]  I. Pollack,et al.  Low-grade gliomas of the cerebral hemispheres in children: an analysis of 71 cases. , 1995, Journal of neurosurgery.

[252]  V. Sheffield,et al.  Deletion of chromosome arm 17p dna sequences in pediatric high‐grade and juvenile pilocytic astrocytomas , 1995, Genes, chromosomes & cancer.

[253]  J. Krischer,et al.  A phase II study of every other day high-dose ifosfamide in pediatric brain tumors: a Pediatric Oncology Group Study. , 1995, Journal of neuro-oncology.

[254]  J. Schramm,et al.  Gangliogliomas: clinical, radiological, and histopathological findings in 51 patients. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[255]  D. Miller,et al.  Cervicomedullary tumors in children , 1994, Neurology.

[256]  D. Hinton,et al.  The lack of a role for p53 in astrocytomas in pediatric patients. , 1994, Neurosurgery.

[257]  J. Drake,et al.  Development of anaplastic changes in low-grade astrocytomas of childhood. , 1994, Neurosurgery.

[258]  D. Cochrane,et al.  Cytogenetic analysis of 109 pediatric central nervous system tumors. , 1993, Cancer genetics and cytogenetics.

[259]  W. J. Oakes,et al.  Pilocytic astrocytoma: correlation between the initial imaging features and clinical aggressiveness. , 1993, AJR. American journal of roentgenology.

[260]  P. Burger,et al.  Carboplatin treatment of progressive optic pathway gliomas to delay radiotherapy. , 1993, Journal of neurosurgery.

[261]  M. Prados,et al.  Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[262]  C. Griffin,et al.  Chromosome abnormalities in low-grade central nervous system tumors. , 1992, Cancer genetics and cytogenetics.

[263]  F. Gilles,et al.  Cytogenetic analysis of 39 pediatric central nervous system tumors. , 1992, Cancer genetics and cytogenetics.

[264]  R. Prayson,et al.  Dysembryoplastic neuroepithelial tumor. , 1992, American journal of clinical pathology.

[265]  W. J. Oakes,et al.  Treatment of children with progressive or recurrent brain tumors with carboplatin or iproplatin: a Pediatric Oncology Group randomized phase II study. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[266]  M. Wigler,et al.  The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins , 1990, Cell.

[267]  J. Bruner,et al.  Juvenile pilocytic astrocytomas: CT and MR characteristics. , 1989, AJR. American journal of roentgenology.

[268]  L. Rorke,et al.  Leptomeningeal dissemination of low‐grade gliomas in childhood , 1988, Neurology.

[269]  J. Rey,et al.  Chromosomal composition of a series of 22 human low-grade gliomas. , 1987, Cancer genetics and cytogenetics.

[270]  R. Schmutzler,et al.  GFAP in brain tumor diagnosis: possibilities and limitations. , 1985, Pathology, research and practice.

[271]  W F Taylor,et al.  Neurosurgical management of low-grade astrocytoma of the cerebral hemispheres. , 1984, Journal of neurosurgery.

[272]  S. Waga,et al.  Diencephalic syndrome of emaciation (Russell's syndrome). , 1982, Surgical neurology.

[273]  Michael E. Cohen,et al.  Chemotherapy in recurrent noncystic low‐grade astrocytomas of the cerebrum in children , 1978, Journal of surgical oncology.

[274]  A. Evans,et al.  Response to vincristine of recurrent brain tumors in children. , 1976, Journal of neurosurgery.

[275]  K. McMartin,et al.  Formate assay in body fluids: application in methanol poisoning. , 1975, Biochemical medicine.